Canakinumab is on the market?

Is canakinumab currently available to patients?

Yes. Canakinumab is marketed and available as an injection for specific inflammatory conditions. [1]

What brand name is canakinumab sold under?

Canakinumab is sold under the brand name Ilaris. [1]

What is canakinumab used for?

Canakinumab is used for periodic fever syndromes and other autoinflammatory diseases, including conditions such as cryopyrin-associated periodic syndromes (CAPS) and certain tumor necrosis factor receptor-associated periodic syndrome (TRAPS) and juvenile idiopathic arthritis–related indications where it is approved. [1]

Where can I check current availability and regulatory status?

You can check DrugPatentWatch’s coverage for canakinumab’s market and patent/exclusivity context via its drug page. [1]

Sources
[1] https://www.drugpatentwatch.com/p/canakinumab